BS
Brian Skorney Baird Latest Price Targets & Analyst Ratings
| Stock | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|
1
Biohaven
BHVN
$1.7B
| $16.07 | $52 |
224%
upside
| Outperform | 24 days ago |
|
2
Sarepta Therapeutics
SRPT
$1.93B
| $18.46 | $35 |
90%
upside
| Outperform | 1 month ago |
|
3
Soleno Therapeutics
SLNO
$3.7B
| $69.57 | $121 |
74%
upside
| Outperform | 1 month ago |
|
4
Dyne Therapeutics
DYN
$1.88B
| $13.24 | $32 |
142%
upside
| Outperform | 2 months ago |
|
5
Biogen
BIIB
$20.5B
| $139.94 | $255 |
82%
upside
| Outperform | 4 months ago |
|
6
Regeneron Pharmaceuticals
REGN
$60.1B
| $567.22 | $587 |
3%
upside
| Neutral | 4 months ago |
|
7
Mirum Pharmaceuticals
MIRM
$3.73B
| $74.18 | $55 |
26%
downside
| Outperform | 6 months ago |
|
8
Gilead Sciences
GILD
$140B
| $112.77 | $100 |
11%
downside
| Neutral | 6 months ago |
|
9
Benitec Biopharma
BNTC
$368M
| $14 | $30 |
114%
upside
| Outperform | 8 months ago |
|
|
ALMS
10
Alumis Inc. Common Stock
ALMS
$479M
| $4.60 | $25 |
443%
upside
| Outperform | 10 months ago |
|
11
Amgen
AMGN
$151B
| $280.10 | $215 |
23%
downside
| Underperform | 11 months ago |
|
12
Neurocrine Biosciences
NBIX
$13.9B
| $140.40 | $180 |
28%
upside
| Outperform | 1 year ago |
|
13
Lexeo Therapeutics
LXEO
$268M
| $4.97 | $28 |
463%
upside
| Outperform | 1 year ago |
|
14
Crinetics Pharmaceuticals
CRNX
$3.23B
| $34.25 | $62 |
81%
upside
| Outperform | 1 year ago |
|
15
Regenxbio
RGNX
$498M
| $9.42 | $39 |
314%
upside
| Outperform | 1 year ago |
|
16
Xenon Pharmaceuticals
XENE
$2.98B
| $38.64 | $63 |
63%
upside
| Outperform | 1 year ago |
|
17
Vertex Pharmaceuticals
VRTX
$102B
| $396.93 | $325 |
18%
downside
| Neutral | 2 years ago |
|
18
Immunovant
IMVT
$2.81B
| $16.12 | $10 |
38%
downside
| Neutral | 4 years ago |
|